Annovis Bio, Inc. 8-K

What Happened Annovis Bio, Inc. (ANVS) announced on January 28, 2026 that it will conduct a webinar and furnished the webinar presentation under a Form 8‑K Regulation FD disclosure. The company incorporated the presentation by reference in the filing.

Key Details

• Webinar date: January 28, 2026.
• Filing type: Item 7.01 (Regulation FD Disclosure) — presentation furnished to ensure public disclosure.
• Presentation furnished as Exhibit 99 to the Form 8‑K.
• The filing does not report earnings, executive changes, mergers, or other material financial results.

Why It Matters This 8‑K is a public disclosure of a company presentation; investors should review the furnished presentation for any operational or program updates that could be material. The filing itself does not contain financial results or corporate changes, so any investment-relevant information would come from the webinar/presentation content.